Job title: Head of Global Strategic Opportunities
John M. Armstrong, PhD is the Head of Global Strategic Opportunities for the Prescription Strategy and Innovation Group at Galderma S.A. in Vevey, Switzerland. After earning his PhD in Immunology at UT Southwestern Medical Center at Dallas, he completed his first post-doctoral fellowship studying differences in drug biotransformation between different ages, genders, strains, and species at Sandoz Pharmaceutical Company in Basel, Switzerland, and his second post-doctoral fellowship studying signal transduction pathways in animal models of immunodeficiency at the US National Institutes of Health in Bethesda, Maryland. In addition to working in Medical Affairs at Bayer Health Sciences and at Johnson and Johnson, Dr. Armstrong co-founded and ran Lead Horse Technologies, Inc., a personalized medicine company from 2006 to 2012. As Chairman & CEO, he led a team of scientists and physicians to develop an AI-based big data analytics algorithm to apply to millions of real-world patient records to quantify the individual risk of adverse event development in patients with diverse medical profiles. In addition to his focus on bringing external innovation into Galderma’s prescription business, Dr. Armstrong works with key internal and external stakeholders to explore ways to apply personalized medicine approaches to dermatology.
Panel Discussion: Promoting Patient-Centricity in Dermatology 2:15 pm
Establishing patient-facing protocol development and design of development programs Discussing the evolution of Patient Reported Outcomes in dermatology Promoting digital patient tools in dermatology clinical trials (engagement, recruitment, data collection)Read more
day: Day Two